Prevalance and risk factors for yeast colonization in adult diabetic patients

Ethiopian Medical Journal

Volumn 43, Issue 2, 2005, Pages 103-109

  Sahin, Idris ^a   Oksuz, Sukru ^a   Sencan, Irfan ^a   Gulcan, Aynur ^a   Karabay, Oguz ^a   Gulcan, Erim ^a   Yildiz, Ozcan ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; ETHIOPIA; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; THRUSH; YEAST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS, ORAL; DIABETES MELLITUS, TYPE 2; DNA, FUNGAL; ETHIOPIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH; PREVALENCE; RISK FACTORS; YEASTS;

EID: 33644845426     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Miller DJ. Diagnosis and Management of Candida and other fungal infections of the head and neck. Curr Infect Dis Rep 2002; 4:194-200.
2. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 1999; 16:675-9.
3. Committee Expert:Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-97.
4. Kathy F, Caughron EL, Smith D. Definition and Description of Diabetes Mellitus. American Diabetes Association: Clinical Practice Recommendations 2001. Diabetes Care 2001; 24: 1-132.
5. Dedic A, Masic I. Diabetes mellitus and Candida albicans. Med Arh 1999; 53:43-5.
6. Rossie K, Guggenheimer J. Oral candidiasis: clinical manifestations, diagnosis, and treatment. Pract Periodontics Aesthet Dent 1997; 9:635-41.
7. Larone DH: Medically important fungi, a guide to identification. Washington, DC: Am Soc Microbiol, 1995;3.
8. Warren NG & Hazen KC. Candida, Cryptococcus and other yeasts of medical importance. In: Murray PP, Baron EJO, Pfaller MA, Tenover FC, Yolken RH, (editors), In:Manual of Clinical Microbiology, Washington DC: American Society for Microbiology, 1995; 6.
9. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV infected individuals. Microbiology 1995; 141:1507-21.
10. Sullivan D, Coleman D. Candida dubliniensis: Characteristics and identification. J Clin Microbiol 1998; 36:329-34.
11. Tintelnot K, Haase G, Seibold M, Bergmann F, Staemmler M, Franz T et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol; 2000, 38:1599-683.
12. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32:452-6.
13. Pfaller MA, Messer SA, & Hollis RJ. Variation in DNA subtype, antifungal susceptibility, and slime production among clinical isolates of Candida parapsilosis. Diagn Microbiol Infect Dis 1995; 21:9-14.
14. Polak A. Virulence of Candida albicans mutants. Mycoses 1992; 35: 9-16.
15. Price MF, Wilkkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida alibicans. Sabouraudia, 1982; 20:7-14.
16. Fongsmut T, Deerochanawong C, Prachyabrued W. Intraoral Candida in Thai diabetes patients. J Med Assoc Thai 1998; 81:449-53.
17. Willis AM, Coulter WA, Sullivan DJ, Coleman DC, Hayes JR, Bell PM et al. Isolation of C. dubliniensis from insulin-using diabetes mellitus patients. J Oral Pathol Med 2000; 29: 86-90.
18. Wilson RM, Reeves WG. Neutrophil phagocytosis and killing ininsulin-dependent diabetes. Clin Exp Immunol 1986; 63:478-84.
19. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med 1982; 72:439-50.
20. De Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dix 2002; 2:1.
21. Hill LV, Tan MH, Pereira LH, Embil JA. Association of oral candidiasis with diabetic control. J Clin Pathol 1989: 42:502-5.
22. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ. Oral candidal carriage and infection in insulin treated diabetic patients. Diabet Med 1999; 16: 675-9.
23. Manfredi M, Mc Cullough MJ, Al-Karaawi ZM, Hurel SJ, Porter SR. The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol 2002; 17: 181-5.
24. Abu-Elteen KH & Abu-Alteen RM. The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microbiol 1998; 21:41-8.
25. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. TRENDS in Microbiology 2001;9:327-35.